Thomas, F. D., Darrah, J., Graham, L., Berning, A., Blomberg, R., Finstad, K., Griggs, C., Crandall, M., Schulman, C., Kozar, R., Lai, J., Mohr, N., Chenoweth, J., Cunningham, K., Babu, K., Dorfman, J., Van Heukelom, J., Ehsani, J., Fell, J., ... Moore, C. (2022). Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users (Report No. DOT HS 813 399). United States. Department of Transportation. National Highway Traffic Safety Administration. https://doi.org/10.21949/1528609
Thomas, F. D., J Darrah, L Graham, A Berning, R Blomberg, K Finstad, and C Griggs, et al.. Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users. Report no. DOT HS 813 399. United States. Department of Transportation. National Highway Traffic Safety Administration, 2022. https://doi.org/10.21949/1528609.
Thomas, F. D., et al. Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users. United States. Department of Transportation. National Highway Traffic Safety Administration, 2022, Report no. DOT HS 813 399, ROSA P. https://doi.org/10.21949/1528609.
Interest in how drugs other than alcohol affect roadway safety has increased. Studies conducted by NHTSA and others gave insights, but a knowledge gap exists on drug prevalence among drivers, pedestrians, and bicyclists seriously or fatally injured in crashes. This study sought to fill this gap by examining drug prevalence among a large sample (N = 7,279) of seriously injured roadway users at seven trauma centers and fatally injured crash victims at four medical examiners. Overall, 55.8% of the injured or killed tested positive for one or more drugs including alcohol, and, overall, 19.9% tested positive for two or more categories of drugs. The results are a first look at drug prevalence among a large sample of seriously or fatally injured roadway users.
This dataset supports the conclusions of NHTSA report DOT HS 813 399, "Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users." Int
...
This Traffic Tech briefly describes a full report, Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users NHTSA is publishing soon.
...
This dataset supports the conclusions of NHTSA report DOT HS 813 399, "Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users." Int
...
Thomas, F. D., Darrah, J., Graham, L., Berning, A., Blomberg, R., Finstad, K., Griggs, C., Crandall, M., Schulman, C., Kozar, R., Lai, J., Mohr, N., Chenoweth, J., Cunningham, K., Babu, K., Dorfman, J., Van Heukelom, J., Ehsani, J., Fell, J., ... Moore, C. (2022). Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users (Report No. DOT HS 813 399). United States. Department of Transportation. National Highway Traffic Safety Administration. https://doi.org/10.21949/1528609
Thomas, F. D., J Darrah, L Graham, A Berning, R Blomberg, K Finstad, and C Griggs, et al.. Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users. Report no. DOT HS 813 399. United States. Department of Transportation. National Highway Traffic Safety Administration, 2022. https://doi.org/10.21949/1528609.
Thomas, F. D., et al. Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users. United States. Department of Transportation. National Highway Traffic Safety Administration, 2022, Report no. DOT HS 813 399, ROSA P. https://doi.org/10.21949/1528609.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.